Format

Send to

Choose Destination
Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26861. Epub 2017 Oct 19.

Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology.

Author information

1
Department of Pediatric Hematology and Oncology, University Hospital Motol and 2nd Medical School, Charles University, Prague, Czech Republic.
2
Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
3
Pediatric Hematology Oncology Department, Hospital Niño Jesús, Madrid, Spain.

Abstract

Adolescents and young adults (AYA) comprise a specific group of oncology patients with a distinct biological and epidemiological spectrum of central nervous system neoplasms. It has been well documented that they differ clinically, especially in relation to prognosis and chemotherapy tolerance; however, the underlying reasons for this are unclear. Recent advances in the genomics of both childhood and adult brain tumors have provided new explanations and insights into the previously described age-dependent heterogeneity. Herein, we summarize the current state of the AYA population in neuro-oncology, specifically how biological advances can help personalize therapy for this unique group of patients.

KEYWORDS:

adolescents and young adults; brain tumor; glioma; pediatric

PMID:
29049858
DOI:
10.1002/pbc.26861
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center